Concomitant Chemoradiation gives Significant Survival and Hrqol Benefits in Patients with Locally Advanced Stage III Non Small Cell Lung Cancer (NSCLC) Not Eligible for Radical Treatment: A Randomized Trial by the Norwegian Lung Cancer Study Group
作者
Hans Henrik Strøm,Stein Harald Sundstrøm,Nina Helbekkmo,R. M. Bremnes,Ulf Aasebø